title: Retinoids and PPAR agonists: Promising partners in neurodegenerative diseases?
authors.affiliation: Service of Neurology, University Hospital Marques de Valdecilla-IDIVAL, University of Cantabria, Av Valdecilla s/n, 39008 Santander, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Spain. Electronic address: javier.riancho86@gmail.com.
authors.forename: Javier
authors.initials: J
authors.lastname: Riancho
mesh_terms: D000818:Animals; D000077610:Bexarotene; D004195:Disease Models, Animal; D005786:Gene Expression Regulation; D006801:Humans; D051379:Mice; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D047495:PPAR gamma / Q000819:agonists* / Q000235:genetics / Q000378:metabolism; D018168:Receptors, Retinoic Acid / Q000819:agonists* / Q000235:genetics / Q000378:metabolism; D047488:Retinoid X Receptors / Q000819:agonists* / Q000235:genetics / Q000378:metabolism; D013764:Tetrahydronaphthalenes / Q000494:pharmacology*; D014801:Vitamin A / Q000378:metabolism / Q000494:pharmacology
chemical_list: D018696:Neuroprotective Agents; D047495:PPAR gamma; D018168:Receptors, Retinoic Acid; D047488:Retinoid X Receptors; D013764:Tetrahydronaphthalenes; D014801:Vitamin A; D000077610:Bexarotene
keywords: ALS; Amyotrophic lateral sclerosis; Bexarotene; Motor neuron disease; PPAR; Retinoids; Treatment